Cargando…

Log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than N stage

BACKGROUND: Signet ring cell carcinoma is a rare type of oesophageal cancer, and we hypothesized that log odds of positive lymph nodes (LODDS) is a better prognostic factor for oesophageal signet ring cell carcinoma. AIM: To explore a novel prognostic factor for oesophageal signet ring cell carcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feng, Gao, Shu-Geng, Xue, Qi, Tan, Feng-Wei, Gao, Yu-Shun, Mao, You-Sheng, Wang, Da-Li, Zhao, Jun, Li, Yin, Yu, Xiang-Yang, Cheng, Hong, Zhao, Chen-Guang, Mu, Ju-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809653/
https://www.ncbi.nlm.nih.gov/pubmed/33511169
http://dx.doi.org/10.12998/wjcc.v9.i1.24
_version_ 1783637160035876864
author Wang, Feng
Gao, Shu-Geng
Xue, Qi
Tan, Feng-Wei
Gao, Yu-Shun
Mao, You-Sheng
Wang, Da-Li
Zhao, Jun
Li, Yin
Yu, Xiang-Yang
Cheng, Hong
Zhao, Chen-Guang
Mu, Ju-Wei
author_facet Wang, Feng
Gao, Shu-Geng
Xue, Qi
Tan, Feng-Wei
Gao, Yu-Shun
Mao, You-Sheng
Wang, Da-Li
Zhao, Jun
Li, Yin
Yu, Xiang-Yang
Cheng, Hong
Zhao, Chen-Guang
Mu, Ju-Wei
author_sort Wang, Feng
collection PubMed
description BACKGROUND: Signet ring cell carcinoma is a rare type of oesophageal cancer, and we hypothesized that log odds of positive lymph nodes (LODDS) is a better prognostic factor for oesophageal signet ring cell carcinoma. AIM: To explore a novel prognostic factor for oesophageal signet ring cell carcinoma by comparing two lymph node-related prognostic factors, log odds of positive LODDS and N stage. METHODS: A total of 259 cases of oesophageal signet ring cell carcinoma after oesopha-gectomy were obtained from the Surveillance, Epidemiology, and End Results database between 2006 and 2016. The prognostic value of LODDS and N stage for oesophageal signet ring cell carcinoma was evaluated by univariate and multivariate analyses. The Akaike information criterion and Harrell’s C-index were used to assess the value of two prediction models based on lymph nodes. External validation was performed to further confirm the conclusion. RESULTS: The 5-year cancer-specific survival (CSS) and 5-year overall survival (OS) rates of all the cases were 41.3% and 27.0%, respectively. The Kaplan-Meier method showed that LODDS had a higher score of log rank chi-squared (OS: 46.162, CSS: 41.178) than N stage (OS: 36.215, CSS: 31.583). Univariate analyses showed that insurance, race, T stage, M stage, TNM stage, radiation therapy, N stage, and LODDS were potential prognostic factors for OS (P < 0.1). The multivariate Cox regression model showed that LODDS was an significant independent prognostic factor for oesophageal signet ring carcinoma patients after surgical resection (P < 0.05), while N stage was not considered to be a significant prognostic factor (P = 0.122). Model 2 (LODDS) had a higher degree of discrimination and fit than Model 1 (N stage) (LODDS vs N stage, Harell’s C-index 0.673 vs 0.656, P < 0.001; Akaike information criterion 1688.824 vs 1697.519, P < 0.001). The results of external validation were consistent with those in the study cohort. CONCLUSION: LODDS is a superior prognostic factor to N stage for patients with oesophageal signet ring cell carcinoma after oesophagectomy.
format Online
Article
Text
id pubmed-7809653
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-78096532021-01-27 Log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than N stage Wang, Feng Gao, Shu-Geng Xue, Qi Tan, Feng-Wei Gao, Yu-Shun Mao, You-Sheng Wang, Da-Li Zhao, Jun Li, Yin Yu, Xiang-Yang Cheng, Hong Zhao, Chen-Guang Mu, Ju-Wei World J Clin Cases Retrospective Cohort Study BACKGROUND: Signet ring cell carcinoma is a rare type of oesophageal cancer, and we hypothesized that log odds of positive lymph nodes (LODDS) is a better prognostic factor for oesophageal signet ring cell carcinoma. AIM: To explore a novel prognostic factor for oesophageal signet ring cell carcinoma by comparing two lymph node-related prognostic factors, log odds of positive LODDS and N stage. METHODS: A total of 259 cases of oesophageal signet ring cell carcinoma after oesopha-gectomy were obtained from the Surveillance, Epidemiology, and End Results database between 2006 and 2016. The prognostic value of LODDS and N stage for oesophageal signet ring cell carcinoma was evaluated by univariate and multivariate analyses. The Akaike information criterion and Harrell’s C-index were used to assess the value of two prediction models based on lymph nodes. External validation was performed to further confirm the conclusion. RESULTS: The 5-year cancer-specific survival (CSS) and 5-year overall survival (OS) rates of all the cases were 41.3% and 27.0%, respectively. The Kaplan-Meier method showed that LODDS had a higher score of log rank chi-squared (OS: 46.162, CSS: 41.178) than N stage (OS: 36.215, CSS: 31.583). Univariate analyses showed that insurance, race, T stage, M stage, TNM stage, radiation therapy, N stage, and LODDS were potential prognostic factors for OS (P < 0.1). The multivariate Cox regression model showed that LODDS was an significant independent prognostic factor for oesophageal signet ring carcinoma patients after surgical resection (P < 0.05), while N stage was not considered to be a significant prognostic factor (P = 0.122). Model 2 (LODDS) had a higher degree of discrimination and fit than Model 1 (N stage) (LODDS vs N stage, Harell’s C-index 0.673 vs 0.656, P < 0.001; Akaike information criterion 1688.824 vs 1697.519, P < 0.001). The results of external validation were consistent with those in the study cohort. CONCLUSION: LODDS is a superior prognostic factor to N stage for patients with oesophageal signet ring cell carcinoma after oesophagectomy. Baishideng Publishing Group Inc 2021-01-06 2021-01-06 /pmc/articles/PMC7809653/ /pubmed/33511169 http://dx.doi.org/10.12998/wjcc.v9.i1.24 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Cohort Study
Wang, Feng
Gao, Shu-Geng
Xue, Qi
Tan, Feng-Wei
Gao, Yu-Shun
Mao, You-Sheng
Wang, Da-Li
Zhao, Jun
Li, Yin
Yu, Xiang-Yang
Cheng, Hong
Zhao, Chen-Guang
Mu, Ju-Wei
Log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than N stage
title Log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than N stage
title_full Log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than N stage
title_fullStr Log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than N stage
title_full_unstemmed Log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than N stage
title_short Log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than N stage
title_sort log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than n stage
topic Retrospective Cohort Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809653/
https://www.ncbi.nlm.nih.gov/pubmed/33511169
http://dx.doi.org/10.12998/wjcc.v9.i1.24
work_keys_str_mv AT wangfeng logoddsofpositivelymphnodesisabetterprognosticfactorforoesophagealsignetringcellcarcinomathannstage
AT gaoshugeng logoddsofpositivelymphnodesisabetterprognosticfactorforoesophagealsignetringcellcarcinomathannstage
AT xueqi logoddsofpositivelymphnodesisabetterprognosticfactorforoesophagealsignetringcellcarcinomathannstage
AT tanfengwei logoddsofpositivelymphnodesisabetterprognosticfactorforoesophagealsignetringcellcarcinomathannstage
AT gaoyushun logoddsofpositivelymphnodesisabetterprognosticfactorforoesophagealsignetringcellcarcinomathannstage
AT maoyousheng logoddsofpositivelymphnodesisabetterprognosticfactorforoesophagealsignetringcellcarcinomathannstage
AT wangdali logoddsofpositivelymphnodesisabetterprognosticfactorforoesophagealsignetringcellcarcinomathannstage
AT zhaojun logoddsofpositivelymphnodesisabetterprognosticfactorforoesophagealsignetringcellcarcinomathannstage
AT liyin logoddsofpositivelymphnodesisabetterprognosticfactorforoesophagealsignetringcellcarcinomathannstage
AT yuxiangyang logoddsofpositivelymphnodesisabetterprognosticfactorforoesophagealsignetringcellcarcinomathannstage
AT chenghong logoddsofpositivelymphnodesisabetterprognosticfactorforoesophagealsignetringcellcarcinomathannstage
AT zhaochenguang logoddsofpositivelymphnodesisabetterprognosticfactorforoesophagealsignetringcellcarcinomathannstage
AT mujuwei logoddsofpositivelymphnodesisabetterprognosticfactorforoesophagealsignetringcellcarcinomathannstage